Clinical Study of SM3321 With Solid Tumors

Clinical trial NCT06087770 · COMPLETED

Trial details

NCT number: NCT06087770
Sponsor: Beijing StarMab Biomed Technology Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors

Start date: 2023-12-07
Primary completion: 2024-10-29
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.